CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and challenges that biopharma CEOs and presidents can relate to and should be aware of. To submit a CEO Corner article, please follow these guidelines.
Leading And Managing Change During A Time Of Transition And Cultural Transformation
While strategic leadership during times of transition and transformation can be especially challenging, consistently prioritizing organizational goals and strategies is paramount to success.
Leading With Authenticity In Turbulent Times
Today, as we strive to be adaptive and productive during the pandemic, leaders can play an important role in “normalizing” the unthinkable and leading with authenticity and truth has never been more important.
Becoming The CEO
Two years ago, I was destined for retirement. Now, I’m the CEO of a company that is developing an ultra-long-lasting dosage form that will allow people to take their medicine once a week or even once a month.
Insights From A First-Time Biotech CEO
Alessandro Riva, M.D. is a first-time biotech CEO who shares some of the values and leadership strategies he has learned over the years, including how to foster a culture of relentless innovation.
Effective Patient Engagement Starts With Strong Relationships
If patients are always at the heart of why we do what we do, then why do they feel that pharmaceutical companies don’t truly understand their needs?
From Consumer Products CEO To Biopharma CEO
Walter Klemp, CEO of Moleculin, shares several lessons he learned from his consumer-product background.
My Advice To Aspiring Biopharma Entrepreneurs
When it comes to achieving success, a few commonalities have crystallized for me during my 30+ years in the pharma industry. Here I share five key tenets that I have found critical to success over the arc of my career.
Do You Know The 4 Pillars To Drive Stakeholder Value?
Thirty-year pharma veteran Nancy Lurker shares her four pillars on which to build your business and why they are crucial to driving stakeholder value over the mid- to long-term.
The Forgotten Piece Of The Opioid Epidemic — And How It Can Be Addressed
To address the opioid epidemic we need an all-out national prevention effort akin to the one that finally began to slow the AIDS epidemic in the 1990s. Here are four actions that could help “unlock” the problem.
From Academia To Pharma CEO: Challenges And Lessons Learned
“Looking back on my 25 years in academic medical research, I can’t think of a single learning experience that equipped me for the world of entrepreneurship, running a public company, or interacting with the capital markets.”
BEYOND THE PRINTED PAGE
Lawrence Blatt: Biopharma Entrepreneur And Professional Musician
Lawrence Blatt, Ph.D., cofounder and CEO of Aligos Therapeutics, his latest biopharma entrepreneurial venture, provides insight into the music industry, as he happens to also be a professional musician.
A Biopharma CEO Not Focused On Stock Price
BioNTech’s founder and CEO, Ugur Sahin, M.D., Ph.D., subject of an upcoming feature in Life Science Leader, provides perspective on the company’s IPO and stock price as a metric.
Disappointments In Alzheimer’s Therapeutic Development — A Conversation With John LaMattina
A question from a reader for Life Science Leader's popular monthly Ask The Board column, prompts a Q&A discussion with John LaMattina, Ph.D., on the retreat from neuroscience R&D.
LIFE SCIENCE LEADER BLOGS
Readying For A Virtual Fireside Chat With A Biomanufacturing Icon
Biomanufacturing icon Andy Skibo, and Life Science Leader chief editor Rob Wright, on topics and planning for upcoming fireside chat at the American Biomanufacturing Summit 2020 that has now gone virtual.
BIO Digital Makes The Best Of A Bad COVID-19 Situation
Life Science Leader’s Rob Wright provides perspective on BIO Digital 2020, and a recommendation for the session every BIO Digital registered attendee should make time to attend.